Turkish version of the Parkinson's… for Parkinson's (NCT07023224)
Validate scale measuring involuntary movements
- Trial ID
- NCT07023224
- Official Title
- Adaptation Of The Parkinson's Disease Dyskinesia Questionnaire Into Turkish And Its Validity And Reliability In Parkinson's Patient
- Goal
- Validate scale measuring involuntary movements
- Status
- RECRUITING
- Sponsor
- Izmir Bakircay University
- Study Type
- OBSERVATIONAL
- Enrollment
- 130 participants
- Conditions
- Idiopathic Parkinson Disease, Dyskinesias, Quality of Life
- Interventions
- Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26)
Summary For Families
The project aims to make sure the 26-item Parkinson's Disease Dyskinesia Scale (PDYS-26) works well in Turkish for measuring choreic, or dance-like, involuntary movements and how they affect daily activities. Researchers will translate the scale with back translation and a panel of health professionals, give the final Turkish version to 130 people with Parkinson's, and check how its scores match measures of fear of movement, balance tests and confidence, and a Parkinson's quality-of-life questionnaire. Eligible participants are people with idiopathic Parkinson's in early-to-moderate stages (stage 1 to 3 on the usual Parkinson's scale), who have at least some involuntary movements on a standard movement rating, do not have atypical Parkinson's or major other health problems that would affect testing, and score 24 or higher on a brief mental status test.
Locations
- Bakirçay University Çiğli Regional Education Hospital, Izmir, İ̇zmi̇r, Turkey (Türkiye)
- Izmir Bakırçay Univercity, Izmir, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Turkish version of the Parkinson's Disease Dyskinesia Scale (PDYS-26). The project aims to make sure the 26-item Parkinson's Disease Dyskinesia Scale (PDYS-26) works well in Turkish for measuring choreic, or dance-like, involuntary movements and how they affect daily activities. Researchers will translate the scale with back translation and a panel of health professionals, give the final Turkish version to 130 people with Parkinson's, and check how its scores match measures of fear of movement, balance tests and confidence, and a Parkinson's quality-of-life questionnaire. Eligible participants are people with idiopathic Parkinson's in early-to-moderate stages (stage 1 to 3 on the usual Parkinson's scale), who have at least some involuntary movements on a standard movement rating, do not have atypical Parkinson's or major other health problems that would affect testing, and score 24 or higher on a brief mental status test.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 1 month.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.